Carboxyglutamate
|
WikiDoc Resources for Carboxyglutamate |
|
Articles |
|---|
|
Most recent articles on Carboxyglutamate Most cited articles on Carboxyglutamate |
|
Media |
|
Powerpoint slides on Carboxyglutamate |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Carboxyglutamate at Clinical Trials.gov Trial results on Carboxyglutamate Clinical Trials on Carboxyglutamate at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Carboxyglutamate NICE Guidance on Carboxyglutamate
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Carboxyglutamate Discussion groups on Carboxyglutamate Patient Handouts on Carboxyglutamate Directions to Hospitals Treating Carboxyglutamate Risk calculators and risk factors for Carboxyglutamate
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Carboxyglutamate |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
γ-carboxyglutamate is an uncommon amino acid introduced into proteins by a post-translational carboxylation of glutamate. This modification is found, for example, in clotting factors and other proteins of the coagulation cascade. This modification introduces an affinity for calcium ions.